31 – 40 of 69
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Radioimmunoimaging and Radioimmunotherapy of Prostate Cancer. Preclinical evaluation of kallikrein related peptidase 2 targeting
- Contribution to journal › Published meeting abstract
- 2014
-
Mark
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
- Contribution to journal › Article
-
Mark
Cabozantinib Resolves Bone Scans in Tumor-Naive Mice Harboring Skeletal Injuries
- Contribution to journal › Article
-
Mark
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.
- Contribution to journal › Article
-
Mark
Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening : Population based cohort study
- Contribution to journal › Article
-
Mark
Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle.
- Contribution to journal › Article
- 2013
-
Mark
N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
- Contribution to journal › Article
-
Mark
Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition
- Contribution to journal › Article
-
Mark
Low expression of SHP-2 is associated with less favorable prostate cancer outcomes.
- Contribution to journal › Article
-
Mark
Preclinical radioimmunotherapy of prostate cancer with 177Lu-11B6, a 177Lu-labeled monoclonal antibody specifically targeting free, unbound human kallikrein-related peptidase 2
- Contribution to journal › Published meeting abstract
